Ubs Group Ag Biotechnology

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$108 Million
103K
Q3 2024
Added 6.83%
BBIO
Bridge Bio Pharma, Inc.
CALL
$105 Million
4.11M
Q3 2024
Reduced 0.51%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$75.2 Million
71.5K
Q3 2024
Added 6.83%
MRNA
Moderna, Inc.
PUT
$42.6 Million
638K
Q3 2024
Added 109.76%
VRTX
Vertex Pharmaceuticals Inc
PUT
$31.7 Million
68.1K
Q3 2024
Added 30.26%
VRTX
Vertex Pharmaceuticals Inc
CALL
$30.6 Million
65.9K
Q3 2024
Added 30.26%
MRNA
Moderna, Inc.
CALL
$24.8 Million
371K
Q3 2024
Added 109.76%
BNTX
Bio N Tech Se
PUT
$19.9 Million
167K
Q3 2024
Reduced 25.71%
BNTX
Bio N Tech Se
CALL
$10.9 Million
91.5K
Q3 2024
Reduced 25.71%
INSM
Insmed Inc
PUT
$9.36 Million
128K
Q3 2024
Added 32.48%
CRDF
Cardiff Oncology, Inc.
CALL
$1.69 Million
633K
Q3 2024
Added 15.73%
CRSP
Crispr Therapeutics Ag
CALL
$954,000
20.3K
Q3 2024
Added 58.78%
BMRN
Biomarin Pharmaceutical Inc
CALL
$913,000
13K
Q3 2024
Added 123.57%
IMVT
Immunovant, Inc.
PUT
$660,000
24K
Q3 2024
Added 18.13%
NVO
Novo Nordisk A S
CALL
$537,000
4.52K
Q3 2024
Added 4.76%
APLS
Apellis Pharmaceuticals, Inc.
PUT
$389,000
13.5K
Q3 2024
Added 15.52%
NTLA
Intellia Therapeutics, Inc.
CALL
$383,000
18.6K
Q3 2024
Added 8.95%
VNDA
Vanda Pharmaceuticals Inc.
CALL
$299,000
63.8K
Q3 2024
Added 10.8%
MGNX
Macrogenics Inc
CALL
$65,000
20K
Q3 2024
Added 0.55%
BCRX
Biocryst Pharmaceuticals Inc
PUT
$60,000
8K
Q3 2024
Added 8.57%
CYTK
Cytokinetics Inc
CALL
$31,000
600
Q3 2024
Added 4.66%
Filter Shares Options
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email